SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-007164
Filing Date
2018-08-20
Accepted
2018-08-20 17:28:23
Documents
64
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20180630x10q.htm 10-Q 1335308
2 EX-31.1 rsls-20180630ex311d78d82.htm EX-31.1 13654
3 EX-31.2 rsls-20180630ex3126bb872.htm EX-31.2 14865
4 EX-32.1 rsls-20180630ex321551d3a.htm EX-32.1 11969
5 EX-32.2 rsls-20180630ex322a422f3.htm EX-32.2 12084
  Complete submission text file 0001558370-18-007164.txt   6797183

Data Files

Seq Description Document Type Size
6 EX-101.INS rsls-20180630.xml EX-101.INS 1580414
7 EX-101.SCH rsls-20180630.xsd EX-101.SCH 44396
8 EX-101.CAL rsls-20180630_cal.xml EX-101.CAL 56660
9 EX-101.DEF rsls-20180630_def.xml EX-101.DEF 207202
10 EX-101.LAB rsls-20180630_lab.xml EX-101.LAB 368674
11 EX-101.PRE rsls-20180630_pre.xml EX-101.PRE 341453
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 181028998
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Assistant Director 10